Press-release for stocks for JNJ

Sylvia Banderas Coffinet Named CEO of Latino Media Network
Published: 2023-05-02 (Crawled : 18:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.59% | O: 0.45% H: 0.69% C: 0.42%
ceo media network

Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
Published: 2023-05-02 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.59% | O: 0.45% H: 0.69% C: 0.42%
license group collaboration car-t agreement

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
Published: 2023-05-02 (Crawled : 15:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.59% | O: 0.45% H: 0.69% C: 0.42%
car-t

GlycoEra AG Expands Board of Directors and Appoints Santiago Arroyo, MD to its Board of Directors as an independent board member
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -33.69% | O: 0.2% H: 2.1% C: -0.59%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.59% | O: 0.45% H: 0.69% C: 0.42%

Bryn Pharma Expands Corporate Leadership with Three New Executive Hires and Additional Board Appointment
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -16.73% | O: -5.0% H: 1.66% C: 1.66%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.59% | O: 0.45% H: 0.69% C: 0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -14.11% | O: -0.94% H: 0.0% C: 0.0%
ALIM | $3.41 -0.87% -0.88% 48K

Health Technology

| 88.7% | O: 2.26% H: 1.1% C: -3.31%
pharma

FDA Panel Supports Narrow Lynparza Label for Prostate Cancer
Published: 2023-05-01 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.65% | O: -0.06% H: 0.43% C: 0.0%
fda lynparza label cancer

FDA Greenlights First Bi-Monthly Injectable for Schizophrenia, Bipolar 1 Diso...
Published: 2023-05-01 (Crawled : 13:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.65% | O: -0.06% H: 0.43% C: 0.0%
fda

Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer
Published: 2023-05-01 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.65% | O: -0.06% H: 0.43% C: 0.0%

Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer
Published: 2023-04-30 (Crawled : 20:20) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.65% | O: -0.06% H: 0.43% C: 0.0%
tar-200 antibody bladder cancer results study

Genomics Global Market Report 2023: Rising Government Funds for Research Drives Growth
Published: 2023-04-28 (Crawled : 23:00) - prnewswire.com
ANPCY | $1.98 338.38% 930

Manufacturing

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M

Health Technology

| Email alert Add to watchlist
ANPCF | $0.148 641.22% 5K

Health Technology

| Email alert Add to watchlist
report genomics research global growth market

Non-steroidal Anti-inflammatory Drugs Market Report 2023: Quick Authority Approvals by Governments and Increase in Government Initiatives Presents Opportunities
Published: 2023-04-27 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 14.12% | O: 0.23% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -16.75% | O: -1.21% H: 0.12% C: -2.76%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| -6.71% | O: -0.41% H: 0.79% C: 0.79%
RBGLY | $10.35 -2.05% 990K

Manufacturing

| -35.31% | O: 2.25% H: 0.31% C: 0.06%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -15.92% | O: 0.11% H: 1.61% C: 1.42%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.26% | O: -0.12% H: 0.58% C: 0.55%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.39% | O: -0.25% H: 0.97% C: 0.31%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 86.07% | O: 1.96% H: 1.59% C: -0.54%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -16.92% | O: -2.09% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| -7.09% | O: -1.03% H: 1.02% C: 0.28%
report market

Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published: 2023-04-27 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 14.12% | O: 0.23% H: 0.0% C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -21.47% | O: -1.13% H: 0.3% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -8.08% | O: -0.79% H: 0.89% C: 0.72%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.26% | O: -0.12% H: 0.58% C: 0.55%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.39% | O: -0.25% H: 0.97% C: 0.31%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 86.07% | O: 1.96% H: 1.59% C: -0.54%
drug report treatment global growing market

Minimally Invasive Spine Technologies Global Market Report 2023: Sector is Expected to Reach $9.4 Billion by 2032 at a CAGR of 11.45%
Published: 2023-04-27 (Crawled : 16:00) - prnewswire.com
SYK | $325.43 -0.62% 0.0% 1.8M

Health Technology

| 8.91% | O: 0.02% H: 0.37% C: -0.21%
MDT | $79.48 0.37% -0.29% 6.7M

Health Technology

| -11.66% | O: -0.06% H: 1.73% C: 1.62%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.05% | O: 0.17% H: 0.31% C: 0.06%
GMED | $50.35 -0.79% 0.0% 1.1M

Health Technology

| -12.68% | O: 0.07% H: 0.29% C: -0.29%
BSX | $67.33 -0.13% -0.31% 7M

Health Technology

| 31.76% | O: -0.39% H: 2.3% C: 2.22%
NUVA | $39.75 -2.24% -2.29% 0

Health Technology

| -6.93% | O: 0.12% H: 0.34% C: -0.33%
ATEC | $12.54 1.62% 1.59% 1.3M

Health Technology

| -15.73% | O: 0.27% H: 0.54% C: -1.68%
report expected spine reach global market

FDA Questions Efficacy of Merck-AstraZeneca’s Lynparza Ahead of Adcomm
Published: 2023-04-27 (Crawled : 13:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.05% | O: 0.17% H: 0.31% C: 0.06%
fda lynparza

Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.52 -2.59% -2.65% 610K